Eco R1 Capital, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $4.16 Million - $5.47 Million	-223,167 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$21.11 - $28.48 $3.75 Million - $5.06 Million	-177,671 Reduced 44.32%	223,167 $4.91 Million
Q4 2018 Feb 14, 2019	BUY	$24.11 - $31.34 $9.66 Million - $12.6 Million	400,838 New	400,838 $10.8 Million
Q2 2018 Aug 14, 2018	SELL	$17.02 - $35.2 $5.42 Million - $11.2 Million	-318,564 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$19.9 - $32.25 $4.21 Million - $6.82 Million	-211,597 Reduced 39.91%	318,564 $6.34 Million
Q4 2017 Feb 14, 2018	BUY	$22.0 - $30.51 $11.7 Million - $16.2 Million	530,161	530,161 $15.4 Million

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.